Literature DB >> 8378944

Improved neurological recovery of cerebral infarctions after plasmapheretic reduction of lipids and fibrinogen.

M Walzl1, H Lechner, B Walzl, G Schied.   

Abstract

BACKGROUND AND
PURPOSE: High fibrinogen levels have been assessed in cerebrovascular disease with a direct relation to both plasma and whole-blood viscosity, as well as cerebral blood flow. Heparin-induced extracorporeal low density lipoprotein precipitation (HELP) is a new method that safely and effectively reduces fibrinogen and plasma lipoproteins and improves blood flow properties.
METHODS: We studied 26 patients with acute embolic stroke and 22 with multi-infarct dementia. Each received two treatments with HELP within 8 days. Each patient had measurement of the important blood constituents and evaluation of changes in clinical signs and symptoms related to their cerebrovascular disease.
RESULTS: Each HELP treatment safely produced an immediate and significant reduction in rheological measures, including fibrinogen (P < .001), whole-blood viscosity at high and low shear rates, plasma viscosity, and red cell transit time (P < .01 each). Total cholesterol, low density lipoprotein (P < .0001 each), lipoprotein(a) (P < .003), and triglycerides (P < .0001) were also reduced. The treated group in both the acute stroke group and the multi-infarct group showed improvement relative to the untreated control subjects in Mathew scale, Mini-Mental State Examination, and activities of daily living test scores. These uniform improvements persisted at least 3 days past the second HELP treatment.
CONCLUSIONS: These results support the hypothesis that the improved hemorheologic property of blood is an important factor in clinical recovery as well as basic neurological function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8378944     DOI: 10.1161/01.str.24.10.1447

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  3 in total

Review 1.  Low-density lipoprotein apheresis in the treatment of atherosclerosis and other potential uses.

Authors:  P M Moriarty; C A Gibson
Journal:  Curr Atheroscler Rep       Date:  2001-03       Impact factor: 5.113

2.  Association of fibrin monomer polymerization function, cerebrovascular risk factors and ischemic cerebrovascular disease in old people.

Authors:  Mei Hong; Wenning Wei; Hongge Li; Rui Yang; Yan Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

3.  Correction of erythrocyte shape abnormalities in familial hypercholesterolemia after LDL-apheresis: does it influence cerebral hemodynamics?

Authors:  A Iannuzzi; G Bianciardi; F Faccenda; A Gnasso; N Scarpato; L Di Marino; G Iaccarino; C Simoes; G Sacchi; E Weber
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.